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Objectives
----------

To discriminate patients with strong or weak *ex vivo* TNF-α synthesis in response to whole blood stimulation with endotoxin (LPS) and to relate this *ex vivo* response to cytokine balance during and after cardiac surgery with cardiopulmonary bypass (CPB).

Patients and methods
--------------------

19 patients scheduled for coronary artery bypass graft (CABG) with CPB and 29 adult volunteers were entered into the study. Whole blood was stimulated with LPS, incubated for 16 h and TNF-α concentrations determined in the culture supernatant. Results obtained in both patients and volunteers were pooled. Individuals showing TNF-α concentrations lower or higher than the median value of 1052 pg/ml were defined as low and high responders, respectively. In the 19 patients, cytokine balance during and after CPB was evaluated by the plasma concentrations of TNF-α, interleukin (IL)-8 and IL-10.

Results
-------

In patients undergoing cardiac surgery, perioperative cytokine plasma levels were not significantly different in both low and high responders. In these two groups *ex vivo* TNF-α production did not correlate with either TNF-α or IL-8 plasma levels measured during and after CPB. In contrast, *ex vivo* TNF-α production inversely correlated with IL-10 plasma concentrations observed four hours after the end of CPB in the low responder group (Spearman, -0.76, *P*=0.01) and tended to do so in the high responder group (Spearman, -0.62, *P*=0.1).

Conclusion
----------

In our series, the *ex vivo* production of TNF-α does not allow us to predict the magnitude of the systemic inflammatory response related to cardiac surgery, as evaluated by the plasma levels of TNF-α and IL8 during and after CPB. The negative correlation observed between the *ex vivo* TNF-α production and the production of IL-10 after CPB suggests that patients with a low *ex vivo* capability to synthesize the pro-inflammatory TNF-α have a high potential to synthesize the anti-inflammatory cytokine IL-10 *in vivo*. Whether this profile can be considered a risk factor for morbidity after cardiac surgery, as it has been shown for infectious diseases remains to be assessed.
